12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tovanor Breezhaler regulatory update

The Pharmaceutical Affairs and Food Sanitation Council of Japan's Ministry of Health, Labor and Welfare (MHLW) recommended approval of a marketing application from Novartis for NVA237 to treat chronic obstructive pulmonary disease (COPD). Novartis,...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >